Clinical Trial Update: Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2 [NA]

View source ↗

Summary

The clinical trial update notes that Aim 2 of a study on light therapy, metabolic syndrome, and Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Mild Cognitive Impairment, Alzheimer Disease | NA | Status: COMPLETED